1066 related articles for article (PubMed ID: 25834317)
1. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
[TBL] [Abstract][Full Text] [Related]
2. The doses of plasmid backbone plays a major role in determining the HBV clearance in hydrodynamic injection mouse model.
Wang X; Zhu J; Zhang Y; Li Y; Ma T; Li Q; Xu J; Xu L
Virol J; 2018 May; 15(1):89. PubMed ID: 29783985
[TBL] [Abstract][Full Text] [Related]
3. The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model.
Li L; Li S; Zhou Y; Yang L; Zhou D; Yang Y; Lu M; Yang D; Song J
Virol J; 2017 Oct; 14(1):205. PubMed ID: 29070073
[TBL] [Abstract][Full Text] [Related]
4. [Immunosuppressant dexamethasone can significantly extend the expression of hepatitis B virus antigens in the HBV mouse model by hydrodynamic transfection method].
Guo YJ; Wang W; Sun SH; Zeng DB; Zhao GY; Yu H; Guo Y; Tan WJ; Lu SC; Zhou YS
Bing Du Xue Bao; 2010 Jan; 26(1):20-6. PubMed ID: 20329554
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of different hepatitis B virus isolates to interferon-alpha in a mouse model based on hydrodynamic injection.
Song J; Zhou Y; Li S; Wang B; Zheng X; Wu J; Gibbert K; Dittmer U; Lu M; Yang D
PLoS One; 2014; 9(3):e90977. PubMed ID: 24618716
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of an HBV chronic hepatitis B infection mouse model by vivo transduction of HBV cccDNA].
Zhao T; Li X; Yin W; Cai X; Zhang W; Chen F; Lai G; Huang A
Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):260-5. PubMed ID: 25173223
[TBL] [Abstract][Full Text] [Related]
7. CpG oligodeoxynucleotide inhibits HBV replication in a hydrodynamic injection murine model.
Hu W; Huang H; Zhang TY; Mao YY; Wang XJ; Wang SQ
Antivir Ther; 2015; 20(3):289-95. PubMed ID: 25279542
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral backbone-based hepatitis B virus replicon-mediated transfer favours the establishment of persistent hepatitis B virus infection in mice after hydrodynamic injection.
Chuai X; Wang W; Chen H; Deng Y; Wen B; Tan W
Antiviral Res; 2014 Jan; 101():68-74. PubMed ID: 24239872
[TBL] [Abstract][Full Text] [Related]
9. [Study on the differences of two mouse models of hepatitis B virus infection by transduction with rAAV8-1. 3HBV].
Wang G; Dong XY; Tian WH; Yu CJ; Zheng G; Gao J; Wang GJ; Wei GC; Zhou YS; Wu XB
Bing Du Xue Bao; 2012 Sep; 28(5):541-7. PubMed ID: 23233931
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-15 suppresses hepatitis B virus replication via IFN-β production in a C57BL/6 mouse model.
Yin W; Xu L; Sun R; Wei H; Tian Z
Liver Int; 2012 Sep; 32(8):1306-14. PubMed ID: 22380514
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.
Klumpp K; Shimada T; Allweiss L; Volz T; Lütgehetmann M; Hartman G; Flores OA; Lam AM; Dandri M
Gastroenterology; 2018 Feb; 154(3):652-662.e8. PubMed ID: 29079518
[TBL] [Abstract][Full Text] [Related]
12. A new model mimicking persistent HBV e antigen-negative infection using covalently closed circular DNA in immunocompetent mice.
Wang L; Cao M; Wei QL; Zhao ZH; Xiang Q; Wang HJ; Zhang HT; Lai GQ
PLoS One; 2017; 12(4):e0175992. PubMed ID: 28426720
[TBL] [Abstract][Full Text] [Related]
13. Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.
Fung J; Lai CL; Young J; Wong DK; Yuen J; Seto WK; Yuen MF
Am J Gastroenterol; 2011 Oct; 106(10):1766-73. PubMed ID: 21826112
[TBL] [Abstract][Full Text] [Related]
14. [Effects of amantadine and biphenyl dimethyl dicarboxylate on hepatitis B virus in hepatitis B virus replication mice].
Liu F; Jiang Z; Zhou Q; Yu Y; Meng H; Shi Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Apr; 31(2):400-4. PubMed ID: 25039150
[TBL] [Abstract][Full Text] [Related]
15. Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial.
An J; Lim YS; Kim GA; Han SB; Jeong W; Lee D; Shim JH; Lee HC; Lee YS
BMC Gastroenterol; 2017 Jan; 17(1):15. PubMed ID: 28103819
[TBL] [Abstract][Full Text] [Related]
16. A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.
Wiegand J; Wedemeyer H; Finger A; Heidrich B; Rosenau J; Michel G; Bock CT; Manns MP; Tillmann HL
Antivir Ther; 2008; 13(4):547-54. PubMed ID: 18672533
[TBL] [Abstract][Full Text] [Related]
17. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.
Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D
J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792
[TBL] [Abstract][Full Text] [Related]
18. Biological characteristics of the rtA181T/sW172* mutant strain of Hepatitis B virus in animal model.
Dai J; Chen EQ; Bai L; Gong DY; Zhou QL; Cheng X; Huang FJ; Tang H
Virol J; 2012 Nov; 9():280. PubMed ID: 23171829
[TBL] [Abstract][Full Text] [Related]
19. Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.
Gish RG; Chang TT; Lai CL; de Man R; Gadano A; Poordad F; Yang J; Brett-Smith H; Tamez R
J Viral Hepat; 2010 Jan; 17(1):16-22. PubMed ID: 19622117
[TBL] [Abstract][Full Text] [Related]
20. [Study on efficacy and safety of lamivudine and interferon-alpha in treatment of hepatitis B virus transgenic mice with pregnancy].
Li D; Yan YP; Xu DZ; Men K; Zhang JX; Lei XY
Zhonghua Fu Chan Ke Za Zhi; 2005 May; 40(5):315-9. PubMed ID: 15938781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
